Drugs / Sulindac 150 MG
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01483144 | Oct 2013 → Nov 2018 | classic familial adenomatous polyposis | Cancer Prevention Pharmaceuticals, Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Sulindac 150 MG | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01483144 ↗ |
| Route | Oral | “Sulindac \[one tablet orally once a day\]” NCT01483144 ↗ |